Multilateral Initiative on Malaria (MIM) Society 8th Pan-African Malaria Conference
In April 2024 Simon, Angela and Sarah attended the Multilateral Initiative on Malaria (MIM) Society 8thPan-African Malaria Conference, organised by the MIM Society in collaboration with the Ministry of Health-Rwanda and the Rwanda Biomedical Centre, in Kigali, Rwanda. Held every 4 years, the MIM conference convenes global experts to discuss the latest achievements, research and innovations in malaria prevention and treatment. Spread over 5 days, it was a fantastic opportunity to see the latest advances in malaria research, catch-up with colleagues from the wider malaria community and from across the African continent, experience the beautiful city of Kigali and mark World Malaria Day on 25th April.
Both Sarah and Angela gave oral presentations in the Vaccines and Immunology Session: Sarah presented on the VAC080 trial “Delayed boosting in 5-17 month old Tanzanian children with the P. falciparum blood-stage malaria vaccine candidate RH5.1/Matrix-M™ induces high-level functional antibodies: a single-centre, Phase 1b trial” and Angela presented the first RH5 vaccine field efficacy data from the VAC091 trial “RH5.1/Matrix-M™, a vaccine candidate against blood-stage P. falciparum malaria; a Phase 2b randomised controlled trial in 5-17 month old children in Burkina Faso”.
Simon participated in a panel discussion, moderated by Dr Gerd Pluschke (Swiss TPH) on “Malaria Vaccines: “On and Beyond the Horizon” along with Prof Leon Mutesa (University of Rwanda), Dr Mary Hamel (WHO) and Dr Ally Olotu (Ifakara Health Institute, Tanzania).
